RemedLtd Past Earnings Performance
Past criteria checks 1/6
RemedLtd's earnings have been declining at an average annual rate of -6.6%, while the Medical Equipment industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 2.6% per year. RemedLtd's return on equity is 11%, and it has net margins of 20.8%.
Key information
-6.6%
Earnings growth rate
-10.0%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 2.6% |
| Return on equity | 11.0% |
| Net Margin | 20.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Remed Co.,Ltd.'s (KOSDAQ:302550) 43% Price Boost Is Out Of Tune With Revenues
Nov 06
RemedLtd's (KOSDAQ:302550) Profits Appear To Have Quality Issues
Aug 20Would RemedLtd (KOSDAQ:302550) Be Better Off With Less Debt?
Aug 12Investor Optimism Abounds Remed Co.,Ltd. (KOSDAQ:302550) But Growth Is Lacking
Jun 17Revenue & Expenses Breakdown
How RemedLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 23,423 | 4,863 | 7,769 | 3,132 |
| 30 Jun 24 | 21,556 | 2,357 | 7,599 | 3,132 |
| 31 Mar 24 | 18,720 | 441 | 7,951 | 3,164 |
| 31 Dec 23 | 18,536 | 797 | 8,104 | 2,940 |
| 30 Sep 23 | 19,411 | -602 | 7,655 | 2,811 |
| 30 Jun 23 | 21,510 | -88 | 6,884 | 2,811 |
| 31 Mar 23 | 21,646 | 3,662 | 6,510 | 2,628 |
| 31 Dec 22 | 21,363 | 4,000 | 6,409 | 2,426 |
| 30 Sep 22 | 22,833 | 3,819 | 6,597 | 2,722 |
| 30 Jun 22 | 21,223 | 2,608 | 6,557 | 2,722 |
| 31 Mar 22 | 21,484 | 1,255 | 6,329 | 2,712 |
| 31 Dec 21 | 20,195 | 752 | 6,068 | 2,731 |
| 30 Sep 21 | 16,848 | -2,620 | 5,101 | 2,358 |
| 30 Jun 21 | 16,182 | -3,005 | 4,781 | 2,358 |
| 31 Mar 21 | 13,451 | -4,486 | 3,682 | 2,885 |
| 31 Dec 20 | 16,633 | -1,834 | 4,218 | 2,288 |
| 30 Sep 20 | 20,706 | 4,652 | 4,808 | 2,216 |
| 30 Jun 20 | 21,763 | 6,534 | 3,761 | 2,751 |
| 31 Mar 20 | 22,459 | 6,907 | 4,173 | 2,131 |
| 31 Dec 19 | 18,550 | 4,363 | 3,829 | 2,137 |
Quality Earnings: A302550 has a large one-off gain of ₩5.8B impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: A302550 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A302550's earnings have declined by 6.6% per year over the past 5 years.
Accelerating Growth: A302550 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A302550 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.6%).
Return on Equity
High ROE: A302550's Return on Equity (11%) is considered low.